Navigating Biosimilar Approvals: Start Conversations Early, Says IP Lawyer
January 5, 2016
Melissa Fassbender
BioPharma-Reporter.com
Axinn counsel Stacie Ropka was quoted in the BioPharma-Reporter.com article, "Navigating Biosimilar Approvals: Start Conversations Early, Says IP Lawyer."